Results 191 to 200 of about 41,565 (267)

Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years. [PDF]

J Neurol Neurosurg Psychiatry
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Greco A, Sun Z, Lasky T, TOP Investigators.   +8 more
europepmc   +1 more source

NX210c Demonstrates Therapeutic Potential to Restore Blood-Brain Barrier in a QSP Model of Relapsing-Remitting Multiple Sclerosis. [PDF]

Int J Mol Sci
Russo G, Sips F, Catozzi S, Bambury P, Janus A, Torchia M, Di Salvatore V, Emili L, Röshammar D, Pappalardo F, Godfrin Y.   +10 more
europepmc   +1 more source

Patient‑Reported Satisfaction in Relapsing-Remitting Multiple Sclerosis: Advantages of At‑Home Self‑Administered Subcutaneous Ofatumumab Versus Other High‑Efficacy Therapies. [PDF]

Drugs Real World Outcomes
Pastore F, Domenicone E, DellOro P, Lefort C.   +3 more
europepmc   +1 more source

Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: A Real-World Study from Jordan. [PDF]

Medicina (Kaunas)
Al Anber A, Abu Al Karsaneh O, Abuquteish D, Abdallah O, Issa MA, Sa'adeh M, Kilani D.   +6 more
europepmc   +1 more source

Overexpression of ITGB3 in Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients. [PDF]

Int J Mol Sci
Sancho GBV, Buendia-Corona RE, Reyes-Mata MP, Mireles-Ramírez MA, Griñán-Ferré C, Pallàs M, Márquez-Aguirre AL, Pavon L, Arias-Carrión O, Guerrero-García JJ, Ortuño-Sahagún D.   +10 more
europepmc   +1 more source

Prevalence of sexual dysfunction in relapsing-remitting multiple sclerosis and its association with brain and cervical cord MRI findings. [PDF]

Neuroradiol J
Dousty B, Karimi S, Torabi Jahromi A, Alizadeh F, Zeinali-Rafsanjani B, Pishdad P.   +5 more
europepmc   +1 more source

Selected Serum Biomarkers in Patients with Relapsing-Remitting Multiple Sclerosis-A 3-Year Prospective Pilot Study. [PDF]

Med Sci (Basel)
Puz P, Maciejowska K, Gendosz de Carrillo D, Janik M, Lasek-Bal A.   +4 more
europepmc   +1 more source

The Association Between the Occurrence of Sensory Integration Disorders, Depression, and Chronic Fatigue in Patients with Relapsing-Remitting Multiple Sclerosis. [PDF]

J Clin Med
Machowska-Sempruch K, Masztalewicz M, Meller A, Nowacki P, Pawlukowska W.   +4 more
europepmc   +1 more source

Cost-effectiveness of treatment sequences following first-line rituximab in relapsing-remitting multiple sclerosis: a Norwegian microsimulation study. [PDF]

Front Neurol
Huygens S, Versteegh M, Berg-Hansen P, Bjelland SH, Holmøy T, Torkildsen Ø.   +5 more
europepmc   +1 more source

Aberrant long-chain fatty acids metabolism and its interplay with immuno-inflammatory responses in relapsing-remitting multiple sclerosis. [PDF]

Front Immunol
Zhu XX, Wang PJ, Liu HX, Sun P, Yu LM, Yang F.   +5 more
europepmc   +1 more source